HIV-1 Gag p24 Quantikine ELISA Kit

• Reactivity: V
• Applications: ELISA
• Conjugate: HRP

HIV-1 Gag p24 Quantikine ELISA Kit Summary

• Background: The Quantikine™ HIV-1 Gag p24 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure HIV-1 Gag p24 in cell culture supernates.
• Additional Information: Validated for Cell Culture Supernates Only
• Specificity: This assay recognizes HIV-1 Gag p24.
• Source: N/A
• Inter-Assay: See PDF Datasheet for details
• Intra-Assay: See PDF Datasheet for details
• Spike Recovery: See PDF Datasheet for details
• Sample Volume: See PDF Datasheet for details

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: No significant interference observed with available related molecules.

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for HIV-1 Gag p24 Quantikine ELISA Kit

• CA
• Capsid Protein
• HIV1 Gag p24
• HIV-1 Gag p24
• Pr55(Gag)

Background

The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55^Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins which are required for virus particle assembly. p24 is a major viral core structural protein. Its measurement is commonly used as an indicator of HIV-1 infection and viral load.

Publications for HIV-1 Gag p24 (DHP240B)(11)

Publications using DHP240B

• L Vargas, N Valdivieso, F Tempio, V Simon, D Sauma, L Valenzuela, C Beltrán, L Castillo-D, X Contreras-, ML Acevedo, J Acevedo, RI Gonzalez, F Valiente-E, R Soto-Rifo, M Rosemblatt, M Lopez, F Osorio, MR Bono Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies Bmc Medicine, 2022-06-09;20(1):216. 2022-06-09 [PMID: 35676738] (Human)
• ML Acevedo, A Gaete-Arge, L Alonso-Pal, MM de Oca, A Bustamante, A Gaggero, F Paredes, CP Cortes, S Pantano, C Martínez-V, J Angulo, N Le Corre, M Ferrés, MA Navarrete, F Valiente-E, R Soto-Rifo Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Nature Microbiology, 2022-04-01;7(4):524-529. 2022-04-01 [PMID: 35365787] (Human)
• C Pereira-Mo, D Toro-Ascuy, C Ananías-Sá, A Gaete-Arge, C Rojas-Fuen, S Riquelme-B, B Rojas-Aray, F García-de-, P Aguilera-C, J Chnaiderma, ML Acevedo, F Valiente-E, R Soto-Rifo Epitranscriptomic regulation of HIV-1 full-length RNA packaging Nucleic Acids Research, 2022-02-28;0(0):. 2022-02-28 [PMID: 35137199] (Human)
• EA Ozer, LM Simons, OM Adewumi, AA Fowotade, EC Omoruyi, JA Adeniji, OA Olayinka, TJ Dean, J Zayas, PP Bhimalli, MK Ash, AI Maiga, AM Somboro, M Maiga, A Godzik, JR Schneider, JI Mamede, BO Taiwo, JF Hultquist, R Lorenzo-Re Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria Nature Communications, 2022-02-03;13(1):688. 2022-02-03 [PMID: 35115515] (Human)
• B Bhargavan, SM Woollard, JE McMillan, GD Kanmogne CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice Molecular Neurodegeneration, 2021-11-22;16(1):78. 2021-11-22 [PMID: 34809709] (Mouse)
• EA Ozer, LM Simons, OM Adewumi, AA Fowotade, EC Omoruyi, JA Adeniji, TJ Dean, J Zayas, PP Bhimalli, MK Ash, A Godzik, JR Schneider, JI Mamede, BO Taiwo, JF Hultquist, R Lorenzo-Re High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria medRxiv : the preprint server for health sciences, 2021-07-02;0(0):. 2021-07-02 [PMID: 33880483] (Human)
• O Tong, G Duette, TR O'Neil, CM Royle, H Rana, B Johnson, N Popovic, S Dervish, MAE Brouwer, H Baharlou, E Patrick, G Ctercteko, S Palmer, E Lee, E Hunter, AN Harman, AL Cunningham, N Nasr Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype PloS Pathogens, 2021-04-19;17(4):e1009522. 2021-04-19 [PMID: 33872331] (Human)
• JI Mamede, J Griffin, S Gambut, TJ Hope A New Generation of Functional Tagged Proteins for HIV Fluorescence Imaging Viruses, 2021-02-28;13(3):. 2021-02-28 [PMID: 33670986] (Human)
• C Beltrán-Pa, S Riquelme-B, A Oyarzún-Ar, A Gaete-Arge, R González-S, K Cereceda-S, A Aguirre, D Travisany, R Palma-Veja, GP Barriga, A Gaggero, C Martínez-V, NL Corre, M Ferrés, ME Balcells, J Fernandez, E Ramírez, F Villarroel, F Valiente-E, R Soto-Rifo Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile Science Advances, 2021-02-12;7(7):. 2021-02-12 [PMID: 33579701] (Human)
• F Regent, L Morizur, L Lesueur, W Habeler, A Plancheron, K Ben M'Bare, C Monville Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions Sci Rep, 2019-07-23;9(1):10646. 2019-07-23 [PMID: 31337830] (Human)
• B Bhargavan, GD Kanmogne Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses Sci Rep, 2019-07-23;9(1):10689. 2019-07-23 [PMID: 31337802] (Human)